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1. Introduction
Most current Implantable Cardioverter Defibrillators (ICD) use intracardiac leads for
electrogram (EGM) sensing and defibrillation (Belott & Reynolds, 2007). Intracardiac leads
consist of several electrodes that for the basic functionality of ventricular tachyarrhythmia
detection and termination, are inserted transvenously into the right ventricle (Gradaus et al.,
2003; Swerdlow et al., 2007). In addition to intracardiac electrodes, ICD also use the casing of
the implant as an indifferent, distant electrode.
In ICD technology, three main intracardiac lead configurations are distinguished based on the
combination of electrodes that they use, namely unipolar, dedicated bipolar and integrated
bipolar. Unipolar leads, so-called because they use the casing of the implant as an indifferent
electrode, consist of a single electrode located in the right ventricle, whereas bipolar leads,
both dedicated and integrated, consist of two closely spaced electrodes located in the right
ventricle. In general, unipolar lead configurations are used for cardiac defibrillation, while
bipolar lead configurations are used for EGM sensing, i.e. they provide with the EGM signals
from which heart rhythm can be extracted.
Previous studies indicate that lead configuration can affect EGM sensing and ICD
performance. For instance, it is well known that fundamental EGM features such as
wave duration, wave amplitude and power spectrum, depend on the configuration of the
recording leads (DeCaprio et al., 1977; Jenkins, 1992; Langberg et al., 1988; Parsonnet et al.,
1980). Also, differences in ventricular fibrillation detection and redetection times have been
reported when comparing ICD dedicated and integrated bipolar leads (Cooklin et al., 1999;
Frain et al., 2007; Goldberger et al., 1998; Natale et al., 1996). Other studies have addressed
the effects on EGM sensing, of artifacts originating from non-ventricular bioelectric sources.
For example, inappropriate ICD discharges have been ascribed to myopotentials oversensing
(Deshmukh & Anderson, 1998; Kowalski et al., 2008; Sandler & Kutalek, 1994; Schulte et al.,
2001). Pacing stimulus artifacts, which are often associated to ICD undersensing, have been
found to be greater in integrated than in dedicated bipolar leads (Menz et al., 1998). Finally,
an optimized lead design for atrial sensing has been proposed, in order to facilitate rejection
of artifacts such as R-waves and myopotentials (Nash et al., 2005). Therefore, the existing
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evidence indicates that by carefully designing ICD intracardiac leads, EGM sensing and hence
ICD overall performance can be further improved.
The effects of lead configuration on ICD sensing performance can be explored through
the notion of lead sensitivity distribution, also known as lead field. The lead sensitivity
distribution describes the ability of leads to measure the electrical activity generated by
bioelectric organs and tissues in the body and hence, it can help to identify the sources
of bioelectric artifacts and to quantify their effects. In addition to this, the analysis of
the lead sensitivity distribution can contribute to widen the range of functionality of ICD
systems by providing with an estimation of lead spatial resolution. The quantification of
the lead spatial resolution could be of great interest, especially in those scenarios where
the underlying cardiac pathology is caused by local physiological abnormalities such as
myocardial ischemia (Asbach et al., 2006; Bunch & Day, 2008; Williams et al., 2008), or when
the underlying pathology can be related to tissue spatial heterogeneities (Zaitsev et al., 2000).
The sensitivity distributions of two unipolar and two bipolar ICD intracardiac lead
configurations have been investigated in a previous study (Requena-Carrión et al., 2009). By
combining a detailed numerical model of the human thorax and finite difference methods
(FDM), the sensitivity distribution at the ventricles of each lead configuration was obtained.
The sensitivity distribution also allowed to quantify the spatial resolution of each lead
configuration, and significant differences in sensing between different lead configurations
were found. However, a more complete picture of EGM sensing in ICD should account for
the measurement of the activity of other bioelectric sources that could affect ICD performance,
such as myopotentials. The analysis of the sensitivity of intracardiac leads at other bioelectric
sources in the human body would improve our understanding on how electrophysiological
artifacts affect EGM sensing and therefore, it would help to devise new strategies to reject
such artifacts by means of designing new lead configurations.
In this study, the sensitivity distribution of four ICD intracardiac lead configurations is
calculated at the ventricles, the atria and near skeletal muscles. For that purpose, a
detailed computational model of the human thorax is used in combination with numerical
methods. Additionally, a discrimination index which is based on the sensitivity distribution
is used for quantifying differences in sensing at the ventricles, atria and near muscles. This
discrimination index takes the accumulated sensitivity of ICD leads at the ventricles, where
the signals of interest are originated, and compares it with the accumulated sensitivity at the
other bioelectric sources.
2. Principles of bioelectric signals measurement
Bioelectric measurement models consist of two basic elements, namely a bioelectric source
and a volume conductor (Malmivuo & Plonsey, 1995). The bioelectric source is the biological
tissue or organ that generates electric currents for regulating a physiological function, whereas
the volume conductor is the conducting medium in which the bioelectric source resides.
Well-known examples of bioelectric sources are the heart, the brain and the skeletal muscle;
the human body as a whole, on the other hand, behaves electrically as a volume conductor.
As a consequence of the activity of bioelectric sources, a time-varying voltage gradient is
induced across the volume conductor. This voltage gradient can be measured by means of
measurement leads, which consist of at least one pair of electrodes in contact with the volume
conductor. From the point of view of the measurement leads, the time-varying measured
voltage u(t) can be modeled mathematically as a weighted linear combination of the currents
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J(t, v) generated by the bioelectric source V:
u(t) =
∫
V
L(v) · J(t, v)dv. (1)
In this equation L(v) denotes the lead sensitivity distribution and it describes the ability of the
lead to measure the bioelectric currents J(t, v) generated by the source at v ∈ V. In general,
since the lead sensitivity distribution will be larger in some regions of the bioelectric source
than in others, the contribution to the total measured voltage will vary from one region within
the bioelectric source to another. As a consequence, it can be said that the lead sensitivity
distribution focus the measurement on selected regions within the bioelectric source and
therefore, the lead sensitivity distribution will define a characteristic lead spatial resolution.
Whenever more than one bioelectric source reside within the volume conductor, by virtue of
the superposition principle the total voltage measured by the leads can be expressed as the
sum of the voltages induced by each source independently. For example, if two sources V1
and V2 exist, the total voltage u(t) will be expressed as:
u(t) = u1(t) + u2(t) =
∫
V1
L(v) · J(t, v)dv +
∫
V2
L(v) · J(t, v)dv, (2)
where u1(t) and u2(t) are the voltages generated by sources V1 and V2, respectively. In this
scenario, the lead sensitivity distribution will determine the contribution of each region V1
and V2 to the total measured voltage. If, for instance, L(v) is much larger in V1 than in V2,
the contribution of V1 to the total measured voltage u(t) will be expected to be higher than
the contribution of V2. Consequently, the lead sensitivity distribution, in addition to define
the lead spatial resolution, will also allow to investigate the ability of a measurement lead to
discriminate between different bioelectric sources.
Since the lead sensitivity distribution depends on both the volume conductor and the design
and arrangement of the measurement leads, different leads will be characterized by different
measurement properties. Based on the analysis of the lead sensitivity distribution, several
techniques have been devised in the literature for investigating how current lead systems
measure bioelectric phenomena. One of the earliest and most popular methods is the analysis
of iso-sensitivity surfaces, which consists of depicting the surfaces in the bioelectric source
where the magnitude of the lead sensitivity distribution remains constant. This analysis
method was used by Rush and Driscoll for describing electroencephalographic (EEG) leads
(Rush & Driscoll, 1969) and by Arzbaecher et al. for investigating the sensitivity of precordial
and esophageal electrocardiographic (ECG) leads (Arzbaecher et al., 1979).
The sensitivity distribution has also been the basis for quantifying the lead spatial resolution.
Based on the estimation of iso-sensitivity surfaces, Malmivuo et al. proposed the half
sensitivity volume (HSV), which was defined as the bioelectric region enclosed by the surface
where the sensitivity magnitude drops to half of the maximum sensitivity (Malmivuo et al.,
1997). By using the HSV, the spatial resolutions of EEG and magnetoencephalography
systems were compared. Also, by combining sensitivity distribution models and numerical
simulations of cardiac dynamics, Requena-Carrión et al. proposed the resolution volume
(ResV) for quantifying lead spatial resolution (Requena-Carrión et al., 2007). The ResV
was defined as the bioelectric region that contributes to a given fraction of the measured
signal power, and it was used for quantifying the spatial resolution of surface ECG leads
(Requena-Carrión et al., 2007) and intracardiac leads in ICD (Requena-Carrión et al., 2009).
Finally, Väisänen et al. further explored the notion of lead spatial resolution by proposing
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ICD Casing
Height (mm) 64
Width (mm) 51
Depth (mm) 15
Helix
Length (mm) 2
Diameter (mm) 3
Ring
Length (mm) 3
Diameter (mm) 3
Right ventricular coil
Length (mm) 57
Diameter (mm) 3
Interelectrode spacing
Helix-Ring (mm) 8
Helix-Coil (mm) 12
Table 1. Electrode specifications.
the region of interest sensitivity ratio (ROISR), defined as the ratio between the average
sensitivities of any two regions within the bioelectric source (Väisänen et al., 2008). The
ROISR allowed to quantify the specificity of EEG (Väisänen et al., 2008) and surface ECG
measurements (Väisänen & Hyttinen, 2009).
In summary, the lead sensitivity distribution constitutes both a useful theoretical tool for
understanding the nature of bioelectric signals, and a useful practical tool for describing
quantitatively the sensing properties of measurement leads. In this study, the sensitivity
distribution will be used to quantify and compare the ability of four ICD intracardiac leads
to measure ventricular bioelectrical events and reject bioelectrical artifacts from the atria and
near muscles. For that purpose, the sensitivity distribution of each lead configuration under
investigation will be analyzed and in addition to this, a measure of discrimination based on
the sensitivity distribution will be proposed.
3. Methods
3.1 Intracardiac ICD leads
The measurement properties of four ICD intracardiac lead configurations (two unipolar, one
dedicated bipolar and one integrated bipolar) were investigated. In order to define the
geometry and the anatomical location of the electrodes that formed each intracardiac lead,
a commercial ICD system was used as a reference model. This system consisted of two
elements, namely the Medtronic Secura ICD (Medtronic, 2008) and the Medtronic Sprint
Quattro Secure ventricular lead (Medtronic, 2010). The Medtronic Secura ICD is a single
chamber ICD which is used in combination with a right ventricular lead for analyzing heart
rhythm and providing defibrillation, cardioversion and both bradycardia and antitachycardia
pacing therapies. As for the Medtronic Sprint Quattro Secure, it is a quadripolar ventricular
lead designed for pacing, sensing, cardioversion and defibrillation therapies.
The Secura ICD is intended to be located in the pectoral region. Its casing, which can be used
as an indifferent, distant electrode, has the physical dimensions shown in Table 1. As for the
Sprint Quattro Secure ventricular lead, it consists of a helix electrode located at the tip of the
lead, followed consecutively by a ring electrode, a right ventricular coil and a superior vena
cava coil. The helix and the ring electrode are used for EGM sensing and pacing, while both
coils in combination with the ICD casing are used for defibrillation. Since this study focuses
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Unipolar A helix to casing
Unipolar B coil to casing
Dedicated bipolar helix to ring
Integrated bipolar helix to coil
Table 2. Intracardiac leads definition.
on bioelectric measurement of ventricular events, the electrodes that were considered were the
helix, the ring and the right ventricular coil. The physical dimensions and relative distances
of the electrodes that were considered for this study are shown in Table 1.
Based on the aforementioned electrode specifications, the four intracardiac ICD leads were
defined as follows (Table 2): the unipolar A lead used the casing of the implant and the helix
electrode; the unipolar B lead used the casing of the implant and the right ventricular coil;
the dedicated bipolar lead used the helix and the ring electrodes and finally, the integrated
bipolar lead used the helix electrode and the right ventricular coil.
3.2 Computational model of the human thorax
A realistic 3D computational model of the bioelectric properties of the human thorax was
implemented for calculating the lead sensitivity distributions. This computational model
was defined based on the widely used Visible Human Man dataset, and consisted of a
341×594×394 cubic grid with a 1 mm×1 mm×1 mm resolution (Sachse et al., 1998). The
human thorax model was segmented into 20 different organ and tissue types, including the
atria, the ventricles and near muscles, and they were assigned resistivity values previously
reported in the literature (Gabriel et al., 1996).
Lead sensitivity distributions were calculated in the realistic human thorax by applying
the principle of reciprocity (Malmivuo & Plonsey, 1995), which states that when a lead is
reciprocally energized, the current field that is induced in the volume conductor corresponds
to the lead sensitivity distribution. An FDM approach was developed for calculating the
current field induced in the realistic human thorax when each electrode pair was reciprocally
energized. The FDM solver was based on the Incomplete Cholesky Preconditioner and
Conjugate Gradient (Takano, 2002) and was executed on an AMD 3000+ 64Bit, 2 GB RAM,
200GB SATA RAID computer.
3.3 Discrimination power
Lead sensitivities at the ventricles were compared to lead sensitivities at the atria and
near muscles. For that purpose, two discrimination indices based on the notion of ROISR
(Väisänen et al., 2008) were defined as follows:
diAV =
∫
atria |L(v)|dv∫
ventricles |L(v)|dv
(3)
diMV =
∫
muscle |L(v)|dv∫
ventricles |L(v)|dv
The discrimination index diAV allowed to compare the accumulated sensitivities at the atria
with the accumulated sensitivities at the ventricles, whereas the diMV allowed to compare the
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accumulated sensitivities at near skeletal muscles with the accumulated sensitivities at the
ventricles. A logarithmic transformation was subsequently applied to both indices:
DIAV = 20 log10 (diAV) (4)
DIMV = 20 log10 (diMV)
Consequently, the lower the value of a discrimination index for a given lead, the lower the
sensitivity of that lead to the corresponding non-ventricular source (atria or skeletal muscle)
and therefore, the lower the effects of bioelectric artifacts from that source.
4. Results
The analysis of the sensitivity distribution of each intracardiac lead reveals that, irrespective
of the lead configuration and design, sensitivity is always higher at the close proximity of
the electrodes and decreases with the distance. Specifically, as shown in Figures 1 and 2, the
sensitivity of configurations using the signal provided by the helix electrode, i.e. unipolar
A, dedicated bipolar and integrated bipolar, is highest near the ventricular apex, into which
the helix electrode is usually inserted; similarly, the sensitivity across the ventricular septum
is significantly higher in configurations using the right ventricular coil, i.e. unipolar B and
integrated bipolar configurations. Figures 1 and 2 also show that the sensitivity of unipolar
configurations decreases more slowly with the distance to the electrodes than the sensitivity
of bipolar configurations and therefore, unipolar measurements are more uniform throughout
the heart than bipolar measurements. In other words, bipolar configurations concentrate their
measurements more than unipolar configurations.
As a consequence of the previous observation, since intracardiac ICD leads are inserted
into the right ventricle, their sensitivity at the ventricular myocardium is higher than at
the atrial myocardium. However, it is worth noting that the sensitivity distribution at the
atria depends on the configuration of the lead. As seen in Figures 1 and 2, in the case of
unipolar configurations the sensitivity distribution at the atria is of roughly the same order
of magnitude as the sensitivity distribution at the ventricles, whereas in the case of bipolar
configurations, the sensitivity distribution drops several orders of magnitude. In addition to
this, by comparing bipolar configurations it can be concluded that the sensitivity at the atria
is higher in the case of integrated bipolar than in the case of dedicated bipolar. Finally, by
invoking the same physical principle according to which lead sensitivity decreases with the
distance to the electrodes, since ICD are usually implanted in the pectoral area, the sensitivity
at the pectoral muscle will be higher for unipolar leads, in which the casing of the implant acts
as the indifferent electrode.
By calculating the discrimination indices DIAV and DIMV , the previous qualitative
observations based on the analysis of the sensitivity distribution can be quantitatively
contrasted. As Table 3 shows, the accumulated sensitivity of bipolar leads is several orders
of magnitude higher at the ventricles than at the other non-ventricular bioelectric sources,
namely the atria and near muscles. In addition to this, it can be noticed that dedicated bipolar
configurations have a higher discrimination power than integrated bipolar configurations.
Unipolar configurations, on the contrary, are characterized by a lower discrimination power,
especially against muscular artifacts due to the proximity to the casing of the ICD. In
general, it can be concluded from this analysis that the unipolar B configuration using the
right ventricular coil and the casing of the implant, is the most vulnerable intracardiac
configuration, whereas the dedicated bipolar configuration is the most robust configuration
against bioelectric artifacts.
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Unipolar A configuration (helix to casing)
Unipolar B configuration (coil to casing)
 
 
−5 −4 −3 −2 −1 0 1 2
Fig. 1. Sensitivity distributions of unipolar intracardiac configurations at two cross-sections
of the heart (arbitrary units, logarithmic scale).
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Dedicated bipolar configuration (helix to ring)
Integrated bipolar configuration (helix to coil)
 
 
−5 −4 −3 −2 −1 0 1 2
Fig. 2. Sensitivity distributions of bipolar intracardiac configurations at two cross-sections of
the heart (arbitrary units, logarithmic scale).
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Discrimination power (dB)
DIAV DIMV
Unipolar A -33 -13
Unipolar B -15 -2
Dedicated bipolar -61 -57
Integrated Bipolar -48 -50
Table 3. Discrimination power against atrial and muscular artifacts.
5. Conclusions
Current ICD tachyarrhythmia detection algorithms use heart rhythm criteria to determine
whether patients are suffering from a life-threatening arrhythmia. In order to extract heart
rhythm, ICD currently estimate the duration of the RR interval on a beat-to-beat basis
by sensing ventricular activations in EGM signals, which are continuously recorded by
intracardiac leads. As a consequence, ICD overall performance depends on the ability
of intracardiac leads to measure ventricular bioelectric events and reject other biolectric
events of non-ventricular origin, which include myopotentials (Deshmukh & Anderson,
1998; Kowalski et al., 2008; Sandler & Kutalek, 1994; Schulte et al., 2001) and pacing stimulus
artifacts (Menz et al., 1998).
It is widely acknowledged that lead design can affect EGM sensing and therefore ICD
performance. On the basis that bipolar configurations are more specific to ventricular events
than unipolar configurations, current ICD use bipolar leads, either dedicated or integrated,
for EGM sensing, while unipolar-like leads are mainly used for cardiac defibrillation. In a
previous study, the sensitivity distribution of two unipolar and two bipolar intracardiac ICD
leads were investigated in a numerical model of the ventricles (Requena-Carrión et al., 2009).
This study showed quantitatively that bipolar leads concentrate their measurements more
than unipolar leads and therefore, provide with ventricular events at a more local level than
unipolar leads, which are characterized by global measurements.
In the present study, the investigation previously developed in (Requena-Carrión et al., 2009)
has been extended by including the analysis of the sensitivity distribution at the atria and
near muscles. Four intracardiac leads based on a current ICD commercial system have been
studied in a computational model of the human thorax. Our analysis supports the view
that bipolar configurations concentrate their measurement on a local level, while unipolar
configurations provide with global measurements. In addition to this, we have been able
to analyze qualitatively the sensitivity distribution at the ventricular and atrial myocardium,
showing that the sensitivity distribution of unipolar configurations is roughly of the same
order of magnitude at the atria and at the ventricles, whereas the sensitivity distribution of
bipolar configurations drops several orders of magnitude from the ventricles to the atria. In
order to analyze quantitatively the sensitivity to non-ventricular bioelectric sources, we have
proposed a discrimination index that compares the accumulated sensitivity at the ventricles
with the accumulated sensitivity at other non-ventricular bioelectric sources. Our results
reveal that bipolar configurations are more specific to ventricular sources than unipolar
configurations and hence, less vulnerable to bioelectric artifacts.
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The notion of lead sensitivity distribution can provide with a useful insight into the nature of
bioelectric signals. In combination with numerical methods, the sensitivity distribution can
help to analyze the performance of current leads and can assist in the design of future leads.
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